
David M Engman MD PhD
Anatomic Pathology, Clinical Pathology
Chairman Emeritus, Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center
Join to View Full Profile
8700 Beverly BlvdLos Angeles, CA 90048
Phone+1 310-423-6627
Dr. Engman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Chairman Emeritus of Pathology at Cedars Sinai Medical Center and Retired Professor of Microbiology-Immunology and Pathology at the Northwestern University Feinberg School of Medicine. Molecular pathologist, scientist and teacher. Advisor to biopharmaceutical industry. Research involves cancer and tropical and emerging infectious diseases.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 1990 - 1995
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 2015 - 2025
- IL State Medical License 1990 - 2023
Awards, Honors, & Recognition
- Fellow American Academy of Microbiology, 2011
- Fellow American Heart Association, 2007
- Member American Society for Clinical Investigation
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAcyl-Protein Thioesterase-like (TbAPT-L) Is a Lipase with Esterase Activity for Short and Medium-Chain Fatty Acids but Has No Depalmitoylation Activity.Robert W B Brown, Aabha I Sharma, Miguel Rey Villanueva, Xiaomo Li, Ouma Onguka
Pathogens. 2022-10-27 - 8 citationsLeishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?Debora B Scariot, Austeja Staneviciute, Jennifer Zhu, Xiaomo Li, Evan A Scott
Frontiers in Cellular and Infection Microbiology. 2022-01-01 - 6 citationsNanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection.Xiaomo Li, Sijia Yi, Débora B. Scariot, Santiago J. Martinez, Ben A. Falk
JCI Insight. 2021-05-10
Professional Memberships
- Fellow
- Member
- Member
- Member
- American Society for Clinical InvestigationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: